{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:04:46Z","timestamp":1769105086859,"version":"3.49.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011852","name":"Paracelsus Medical University","doi-asserted-by":"publisher","award":["DSA10319"],"award-info":[{"award-number":["DSA10319"]}],"id":[{"id":"10.13039\/501100011852","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011852","name":"Paracelsus Medical University","doi-asserted-by":"publisher","award":["DSA10323"],"award-info":[{"award-number":["DSA10323"]}],"id":[{"id":"10.13039\/501100011852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.yexmp.2025.104991","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T16:03:49Z","timestamp":1754755429000},"page":"104991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Drug-eluting coronary stents mediate inflammation-associated protein signature in an experimental in vitro study"],"prefix":"10.1016","volume":"143","author":[{"given":"Vera","family":"Paar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanchao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fitore","family":"Marmullaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta C.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas J.","family":"Motloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lichtenauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2025.104991_bb0005","first-page":"151","article-title":"Toxicity of particulate silicon carbide for macrophages, fibroblasts and osteoblast-like cells in vitro","volume":"5","author":"Allen","year":"1995","journal-title":"Biomed. Mater. Eng."},{"key":"10.1016\/j.yexmp.2025.104991_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fcvm.2014.00015","article-title":"Balloon Angioplasty - The Legacy of Andreas Gr\u00fcntzig, M.D. (1939-1985)","volume":"1","author":"Barton","year":"2014","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0015","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s10495-016-1292-8","article-title":"Peripheral blood mononuclear cell secretome for tissue repair","volume":"21","author":"Beer","year":"2016","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexmp.2025.104991_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/nano10030573","article-title":"Immunomodulatory potential of differently-terminated ultra-small silicon carbide nanoparticles","volume":"10","author":"B\u011blinov\u00e1","year":"2020","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.yexmp.2025.104991_bb0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/heart.89.2.218","article-title":"In-stent stenosis: pathology and implications for the development of drug eluting stents","volume":"89","author":"Bennett","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.yexmp.2025.104991_bb0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(13)62037-1","article-title":"Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial","volume":"383","author":"von Birgelen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.yexmp.2025.104991_bb0035","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.tiv.2014.02.012","article-title":"In vitro cellular responses to silicon carbide particles manufactured through the Acheson process: impact of physico-chemical features on pro-inflammatory and pro-oxidative effects","volume":"28","author":"Boudard","year":"2014","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.yexmp.2025.104991_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130182","article-title":"Optimization of drug delivery by drug-eluting stents","volume":"10","author":"Bozsak","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2025.104991_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.addr.2006.01.021","article-title":"Zotarolimus (ABT-578) eluting stents","volume":"58","author":"Burke","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yexmp.2025.104991_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053078","article-title":"Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study","volume":"8","author":"Buron","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2025.104991_bb0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/eurheartj\/ehp259","article-title":"Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents","volume":"31","author":"Camici","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yexmp.2025.104991_bb0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/FJC.0b013e3180325b0a","article-title":"Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression","volume":"49","author":"Chen","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0065","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00380-017-0947-x","article-title":"Interleukin-1\u03b2 is associated with coronary endothelial dysfunction in patients with mTOR-inhibitor-eluting stent implantation","volume":"32","author":"Chibana","year":"2017","journal-title":"Heart Vessel."},{"key":"10.1016\/j.yexmp.2025.104991_bb0070","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.2174\/138161210794454941","article-title":"Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems","volume":"16","author":"Claessen","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.yexmp.2025.104991_bb0075","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"Costa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yexmp.2025.104991_bb0080","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4244\/EIJV4I4A85","volume":"4","author":"Dahm","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.yexmp.2025.104991_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cyto.2014.02.014","article-title":"An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis","volume":"67","author":"Demyanets","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.yexmp.2025.104991_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197890","article-title":"Endothelial cell activation is attenuated by everolimus via transcriptional and post-transcriptional regulatory mechanisms after drug-eluting coronary stenting","volume":"13","author":"Fejes","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2025.104991_bb0095","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.yexmp.2025.104991_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/cdli.1.3.261-268.1994","article-title":"In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation","volume":"1","author":"Friberg","year":"1994","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0105","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.amjcard.2005.12.037","article-title":"Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome","volume":"97","author":"Gibson","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0110","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1517\/14656566.2014.948844","article-title":"Pharmacological inhibition of coronary restenosis: systemic and local approaches","volume":"15","author":"Guerra","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.yexmp.2025.104991_bb0115","first-page":"375","article-title":"Silicon carbide-coated stents in patients with acute coronary syndrome","volume":"60","author":"Hamm","year":"2003","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.yexmp.2025.104991_bb0120","series-title":"Ischemic Heart Disease: From Diagnosis to Treatment","first-page":"83","article-title":"Epidemiology of ischemic heart disease","author":"Hashim","year":"2023"},{"key":"10.1016\/j.yexmp.2025.104991_bb0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jprot.2012.07.012","article-title":"Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells","volume":"76","author":"Haudek-Prinz","year":"2012","journal-title":"J. Proteome"},{"key":"10.1016\/j.yexmp.2025.104991_bb0130","first-page":"255","article-title":"Silicon carbide coating \u00d1 a semiconducting hybrid Design of Coronary Stents \u00d1 a Feasibility Study","volume":"10","author":"Heublein","year":"1998","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0135","doi-asserted-by":"crossref","first-page":"e910","DOI":"10.4244\/EIJ-D-22-00372","article-title":"Durable polymer versus biodegradable polymer drug-eluting stents in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: a post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial","volume":"18","author":"Hwang","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.yexmp.2025.104991_bb0140","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1253\/circj.CJ-10-0488","article-title":"High plasma interleukin-6 is associated with drug-eluting stent thrombosis: possible role of inflammatory cytokines in the development of stent thrombosis from the Korea stent thrombosis registry","volume":"75","author":"Hwang","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.yexmp.2025.104991_bb0145","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.amjcard.2018.07.040","article-title":"Meta-analysis of the impact of strut thickness on outcomes in patients with drug-eluting stents in a coronary artery","volume":"122","author":"Iantorno","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209841","article-title":"Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery","volume":"14","author":"Ijichi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2025.104991_bb0155","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.yexmp.2025.104991_bb0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0165","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1093\/eurheartj\/ehy633","article-title":"Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions","volume":"39","author":"Kalkman","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yexmp.2025.104991_bb0170","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial","volume":"103","author":"Kastrati","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yexmp.2025.104991_bb0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/CDLI.5.1.78-81.1998","article-title":"Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts","volume":"5","author":"Katial","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0180","first-page":"1284","article-title":"Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathological study","volume":"18","author":"Kawagoe","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.yexmp.2025.104991_bb0185","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.120.051700","article-title":"Durable polymer versus biodegradable polymer drug-eluting stents after percutaneous coronary intervention in patients with acute coronary syndrome: the HOST-REDUCE-POLYTECH-ACS trial","volume":"143","author":"Kim","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.yexmp.2025.104991_bb0190","first-page":"1067","article-title":"Long-term (5-year) clinical evaluation of the resolute zotarolimus-eluting coronary stent: the RESOLUTE US clinical trial","volume":"95","author":"Kirtane","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.yexmp.2025.104991_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004795","article-title":"Impact of stent size selection on acute and long-term outcomes after drug-eluting stent implantation in De novo coronary lesions","volume":"10","author":"Kitahara","year":"2017","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.yexmp.2025.104991_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.866751","article-title":"Thrombosis and inflammation-a dynamic interplay and the role of Glycosaminoglycans and activated protein C","volume":"9","author":"Kohli","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0205","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1160\/TH12-01-0043","article-title":"Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation","volume":"107","author":"Koppara","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.yexmp.2025.104991_bb0210","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(00)03262-1","article-title":"Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis","volume":"356","author":"K\u00f6ster","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.yexmp.2025.104991_bb0215","article-title":"Drug-eluting stents: technical and clinical Progress","volume":"8","author":"Ko\u017alik","year":"2023","journal-title":"Biomimetics (Basel)"},{"key":"10.1016\/j.yexmp.2025.104991_bb0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcin.2010.09.013","article-title":"Late restenosis following sirolimus-eluting stent implantation","volume":"4","author":"Kuriyama","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.yexmp.2025.104991_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yexmp.2025.104991_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12091378","article-title":"Ultrathin struts drug-eluting stents: a state-of-the-art review","volume":"12","author":"Leone","year":"2022","journal-title":"J Pers Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0235","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.RES.76.3.412","article-title":"Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells","volume":"76","author":"Marx","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexmp.2025.104991_bb0240","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jconrel.2022.07.037","article-title":"An intricate interplay between stent drug dose and release rate dictates arterial restenosis","volume":"349","author":"McQueen","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.yexmp.2025.104991_bb0245","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcin.2009.07.007","article-title":"Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial","volume":"2","author":"Meredith","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.yexmp.2025.104991_bb0250","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080340","article-title":"Cellular effects of everolimus and sirolimus on podocytes","volume":"8","author":"M\u00fcller-Krebs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2025.104991_bb0260","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4244\/EIJ-D-20-00539","article-title":"Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis","volume":"17","author":"Nakamura","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.yexmp.2025.104991_bb0265","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.107.762047","article-title":"Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study","volume":"118","author":"Nakazawa","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yexmp.2025.104991_bb0270","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4244\/EIJV10I6A124","article-title":"Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model","volume":"10","author":"Nakazawa","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.yexmp.2025.104991_bb0275","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10554-020-02073-3","article-title":"Inflammation as a determinant of healing response after coronary stent implantation","volume":"37","author":"Ochijewicz","year":"2021","journal-title":"Int. J. Card. Imaging"},{"key":"10.1016\/j.yexmp.2025.104991_bb0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00380-007-1020-y","article-title":"Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention","volume":"23","author":"Ozer","year":"2008","journal-title":"Heart Vessel."},{"key":"10.1016\/j.yexmp.2025.104991_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118474","article-title":"Influence of dabigatran on pro-inflammatory cytokines, growth factors and chemokines - slowing the vicious circle of coagulation and inflammation","volume":"262","author":"Paar","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.yexmp.2025.104991_bb0290","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0735-1097(03)00119-0","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial","volume":"41","author":"Pache","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0295","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","article-title":"In-stent neoatherosclerosis: a final common pathway of late stent failure","volume":"59","author":"Park","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0300","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead083","article-title":"In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways","volume":"3","author":"Pelliccia","year":"2023","journal-title":"Eur Heart J Open."},{"key":"10.1016\/j.yexmp.2025.104991_bb0305","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/cvr\/cvaa072","article-title":"The multiple roles of chemokines in the mechanisms of stent biocompatibility","volume":"117","author":"Ravindran","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexmp.2025.104991_bb0310","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.thromres.2005.06.002","article-title":"Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina","volume":"117","author":"Sardella","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.yexmp.2025.104991_bb0315","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbe.2023.02.001","article-title":"In vitro examinations of the anti-inflammatory interleukin functionalized polydopamine based biomaterial as a potential coating for cardiovascular stents","volume":"43","author":"Sare\u0142o","year":"2023","journal-title":"Biocybernetics Biomed. Eng."},{"key":"10.1016\/j.yexmp.2025.104991_bb0320","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.carrev.2008.03.004","article-title":"Silicon carbide coating of nitinol stents to increase antithrombogenic properties and reduce nickel release","volume":"9","author":"Schmehl","year":"2008","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0325","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","article-title":"TOR, a central controller of cell growth","volume":"103","author":"Schmelzle","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2025.104991_bb0330","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.yexmp.2025.104991_bb0335","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0340","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003354","article-title":"Influence of late vascular inflammation on long-term outcomes among patients undergoing implantation of drug eluting stents: role of C-reactive protein","volume":"5","author":"Shiba","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yexmp.2025.104991_bb0345","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0350","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0355","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4244\/EIJ-D-17-00557","article-title":"State of the art: coronary artery stents - past, present and future","volume":"13","author":"Stefanini","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.yexmp.2025.104991_bb0360","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.4244\/EIJ-D-20-00487","article-title":"Management of myocardial revascularisation failure: an expert consensus document of the EAPCI","volume":"16","author":"Stefanini","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.yexmp.2025.104991_bb0365","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/FJC.0b013e31825aa742","article-title":"Comparative assessment of transient exposure of paclitaxel or zotarolimus on in vitro vascular cell death, proliferation, migration, and proinflammatory biomarker expression","volume":"60","author":"Steinfeld","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0370","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.yexmp.2025.104991_bb0375","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","article-title":"One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial","volume":"109","author":"Stone","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yexmp.2025.104991_bb0380","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00380-013-0357-7","article-title":"The late-phase inflammatory response after drug-eluting stent implantation","volume":"29","author":"Taguchi","year":"2014","journal-title":"Heart Vessel."},{"key":"10.1016\/j.yexmp.2025.104991_bb0385","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41569-019-0234-x","article-title":"Drug-eluting coronary stents: insights from preclinical and pathology studies","volume":"17","author":"Torii","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0390","first-page":"137","article-title":"The next generation endeavor resolute stent: role of the BioLinx polymer system","volume":"3","author":"Udipi","year":"2007","journal-title":"EuroIntervention"},{"key":"10.1016\/j.yexmp.2025.104991_bb0395","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2007.04.022","article-title":"Release profiles in drug-eluting stents: issues and uncertainties","volume":"120","author":"Venkatraman","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.yexmp.2025.104991_bb0400","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/01.CIR.0000041632.02514.14","article-title":"Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans","volume":"106","author":"Virmani","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.yexmp.2025.104991_bb0405","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1515\/CCLM.2007.255","article-title":"Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems","volume":"45","author":"Visvikis-Siest","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0410","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/cmi.2014.24","article-title":"Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation","volume":"12","author":"Vitiello","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.yexmp.2025.104991_bb0415","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41598-024-51496-8","article-title":"Co-release of cytokines after drug-eluting stent implantation in acute myocardial infarction patients with PCI","volume":"14","author":"Wan","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2025.104991_bb0420","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/2211068215611040","article-title":"Local stent-based release of transforming growth factor-\u03b21 limits arterial in-stent restenosis","volume":"21","author":"Wang","year":"2016","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.yexmp.2025.104991_bb0425","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/rb\/rby006","article-title":"Endovascular stent-induced alterations in host artery mechanical environments and their roles in stent restenosis and late thrombosis","volume":"5","author":"Wang","year":"2018","journal-title":"Regen Biomater."},{"key":"10.1016\/j.yexmp.2025.104991_bb0430","doi-asserted-by":"crossref","first-page":"392","DOI":"10.7326\/0003-4819-143-5-200509060-00119","article-title":"Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent","volume":"143","author":"Wessely","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0435","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amsu.2018.12.003","article-title":"Polymer-free versus durable polymer drug-eluting stents in patients with coronary artery disease: a meta-analysis","volume":"38","author":"Wu","year":"2019","journal-title":"Ann Med Surg (Lond)."},{"key":"10.1016\/j.yexmp.2025.104991_bb0440","first-page":"12498","article-title":"IL-8 up-regulates proliferative angiogenesis in ischemic myocardium in rabbits through phosphorylation of Akt\/GSK-3\u03b2(ser9) dependent pathways","volume":"8","author":"Xie","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.yexmp.2025.104991_bb0445","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12872-021-02212-1","article-title":"Association of stent diameter and target vessel revascularization in patients undergoing percutaneous coronary intervention: a secondary retrospective analysis based on a Chinese cohort study","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.yexmp.2025.104991_bb0450","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2016.11.004","article-title":"5-year safety and efficacy of resolute Zotarolimus-eluting stent: the RESOLUTE global clinical trial program","volume":"10","author":"Yeh","year":"2017","journal-title":"JACC Cardiovasc. Interv."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:20:21Z","timestamp":1769044821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480025000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":90,"alternative-id":["S0014480025000413"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.104991","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-eluting coronary stents mediate inflammation-associated protein signature in an experimental in vitro study","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.104991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104991"}}